programas cribado cancer
INICIO / CÁNCER DE MAMA / ACTUALIZACIÓN BIBLIOGRÁFICA / LIFE EXPECTANCY OF SCREEN-DETECTED INVASIVE BREAST CANCER PATIENTS COMPARED WITH WOMEN INVITED TO THE NIJMEGEN SCREENING PROGRAM

Life expectancy of screen-detected invasive breast cancer patients compared with women invited to the Nijmegen screening program

Otten JD, Broeders MJ, Den Heeten GJ, Holland R, Fracheboud J, de Koning HJ, et al. Life expectancy of screen-detected invasive breast cancer patients compared with women invited to the Nijmegen screening program. Cancer 2010 Feb 1;116(3):586-91.PMID:19998346.

Conclusiones: In conclusion, about 40% (360 of 858) of all women with invasive screen-detected breast cancer have the same life expectancy as women from the comparison group (reflecting the general population). For women diagnosed with larger tumors at diagnosis, life expectancy diminishes with increasing tumor size and is modified by screening history.
balidea
web desarrollada y mantenida por :